Structural effect on degradability and in vivo contrast enhancement of polydisulfide Gd(III) complexes as biodegradable macromolecular MRI contrast agents
- 31 May 2009
- journal article
- Published by Elsevier BV in Magnetic Resonance Imaging
- Vol. 27 (4), 503-511
- https://doi.org/10.1016/j.mri.2008.07.020
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Modification of Gd‐DTPA cystine copolymers with PEG‐1000 optimizes pharmacokinetics and tissue retention for magnetic resonance angiographyMagnetic Resonance in Medicine, 2007
- Gadolinium(III)-based blood-pool contrast agents for magnetic resonance imaging: status and clinical potentialExpert Opinion on Drug Delivery, 2007
- Effect of size and charge on pharmacokinetics and in vivo MRI contrast enhancement of biodegradable polydisulfide Gd(III) complexesJournal of Controlled Release, 2006
- Contrast‐enhanced MRI with new biodegradable macromolecular Gd(III) complexes in tumor‐bearing miceMagnetic Resonance in Medicine, 2005
- Extracellular biodegradable macromolecular gadolinium(III) complexes for MRIMagnetic Resonance in Medicine, 2003
- Poly(l-glutamic acid) Gd(III)-DOTA Conjugate with a Degradable Spacer for Magnetic Resonance ImagingBioconjugate Chemistry, 2003
- New Coupling Reagents for the Preparation of Disulfide Cross-Linked Conjugates with Increased StabilityBioconjugate Chemistry, 1997
- Evidence of Gadolinium Dissociation from Protein-DTPA-Gadolinium ComplexesInvestigative Radiology, 1994
- Thiol-containing crosslinking agent with enhanced steric hindranceBioconjugate Chemistry, 1990
- Effect of charged substituents on rates of the thiol-disulfide interchange reactionThe Journal of Organic Chemistry, 1980